227
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

Subcutaneous Tocilizumab in Juvenile Idiopathic Arthritis Associated Uveitis

, MD, , MD, , MDORCID Icon, , MDORCID Icon & , MD
Pages 1997-2000 | Received 17 Sep 2022, Accepted 19 Dec 2022, Published online: 19 Jan 2023

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Renee Liu & Lucia Sobrin. (2024) Options for systemic therapy of uveitis including alternative therapies. Expert Review of Ophthalmology 19:3, pages 211-226.
Read now
Ivan Foeldvari & Harry Petrushkin. (2024) How should we approach management of childhood onset chronic anterior uveitis refractory to adalimumab?. Expert Review of Clinical Immunology 20:3, pages 267-276.
Read now
Ihda M. Bani Khalaf, Hritvik Jain, Nilofar M. Vora, Noor ul Ain, Farhan Murtaza, Muskaan Doulat Ram, Avinash Nankani & Jatin Motwani. (2024) A clearer vision: insights into juvenile idiopathic arthritis–associated uveitis. Baylor University Medical Center Proceedings 37:2, pages 303-311.
Read now
Derrick P. Smit, Ilknur Tugal-Tutkun & Jennifer E. Thorne. (2023) Disease of the Year for 2023: Pediatric Uveitis. Ocular Immunology and Inflammation 31:10, pages 1897-1899.
Read now

Articles from other publishers (2)

Francesca Burlo, Cristina Tumminelli, Serena Pastore, Gabriele Stocco, Debora Curci, Marianna Lucafò, Alberto Tommasini & Andrea Taddio. (2023) Subcutaneous tocilizumab in the management of non-infectious uveitis in children: a brief report. Pediatric Rheumatology 21:1.
Crossref
Claudia Iannone, Luca Marelli, Stefania Costi, Maria Rosa Pellico, Lamberto La Franca, Roberto Caporali & Elisabetta Miserocchi. (2023) Tocilizumab in Juvenile Idiopathic Arthritis Associated Uveitis, a Narrative Review. Children 10:3, pages 434.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.